Renography before heart transplantation in patients with cardiomyopathy

被引:0
作者
Aigner, RM
O'Mara, RE
Fueger, GF
Tscheliessnigg, K
Nicoletti, R
Sorantin, E
Smith, EM
机构
[1] Univ Rochester Hosp, Dept Radiol, Div Nucl Med, Graz, Austria
[2] Univ Rochester Hosp, Dept Surg, Div Transplant Surg, Graz, Austria
关键词
ischemic cardiomyopathy; heart transplantation; dynamic renal scintigraphy; prognosis; renal dysfunction;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In patients with ischemic cardiomyopathy (CM), abnormal renograms may result not only from circulatory failure (which should reverse after transplantation) but also from intrinsic renal disease (which contraindicates heart transplantation). Here, the outcome of heart transplantation was related to preoperative renograms, and the differentiating and prognostic value of renography was analyzed. Methods: The study population consisted of 50 patients with ischemic CM expecting heart transplantation. Anatomical renal pathology was excluded in all patients. Dynamic renal scintigraphy was performed with (99m)Tc-mercaptoacetyltriglycine. Background-subtracted renograms were inspected visually and characterized numerically. Mean parenchymal transit time (mPTT), renal tracer content at 15 min (RTC15) and retention index (RI) were determined. The parametric renogram values were related to a normal reference group of 64 patients. The preoperative renograms were matched with the postoperative outcome. Results: Three characteristic types of symmetrical findings in the kidneys were found: no pathological findings, mildly delayed peak and excretion phase and severely delayed peak and excretion phase. Pathological renograms were observed in 36 of 50 (72%) patients. The mean parametric renogram values in ischemic CM were as follows: Group-A (normal kidney function), mPTT = 142 +/- 26.6 sec, RTC15 = 22.3% +/- 4.6% and RI = 24.7 +/- 11.9; Group B (mild dysfunction), mPTT = 210 +/- 44.0 sec, RTC15 = 42.6% +/- 10.3% and RI = 101.4 +/- 50.5; Group C (severe dysfunction), mPTT = 320 +/- 94.2 sec, RTC15 = 79.6% +/- 15.9% and RI = 347.7 +/- 194.7; and reference patients (normal kidney function), mPTT = 137 +/- 31.1 sec, RTC15 = 22.8% +/- 3.8% and RI = 24.6 +/- 7.9. Postoperative serum creatinine levels were <1.5 mg/dl in all Group A patients, between 1.5 and 2.5 mg/dl in 78% of Group B patients and > 2.5 mg/dl in 75% of Group C patients. Conclusion: Renography revealed abnormal kidney function when structural pathology was excluded. The renographic abnormalities in ischemic CM did not reflect simply the circulatory failure. The numerical grading of renograms allowed patient stratification, suggestive of possible renal insufficiency after cardiac transplantation and immunosuppressive therapy. With further experience, renography may become a useful tool for predicting postoperative outcome in ischemic CM.
引用
收藏
页码:2153 / 2158
页数:6
相关论文
共 50 条
  • [31] Heart Failure in Patients with Arrhythmogenic Cardiomyopathy
    Chen, Shi
    Chen, Liang
    Duru, Firat
    Hu, Shengshou
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [32] Low Aortic Pulsatility Index and Pulmonary Artery Pulsatility Index Are Associated With Increased Mortality in Patients With Dilated Cardiomyopathy Awaiting Heart Transplantation
    Wu, Yihang
    Zhang, Yuhui
    Zhang, Jian
    KOREAN CIRCULATION JOURNAL, 2025, 55 (02) : 134 - 147
  • [33] Current Outcomes in US Children With Cardiomyopathy Listed for Heart Transplantation
    Singh, Tajinder P.
    Almond, Christopher S.
    Piercey, Gary
    Gauvreau, Kimberlee
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 594 - 601
  • [34] Perspectives of patients with terminal heart failure: Quality of life and well being before and in the first year after heart transplantation
    Riedmayr, MI
    Tammen, AR
    Behr, TM
    Wittig, C
    Bullinger, M
    Reichart, B
    Angermann, CE
    ZEITSCHRIFT FUR KARDIOLOGIE, 1998, 87 (10): : 808 - 816
  • [35] Heart Transplantation Outcomes in Radiation-Induced Restrictive Cardiomyopathy
    Al-Kindi, Sadeer G.
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (06) : 475 - 478
  • [36] Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience
    Bouabdallaoui, Nadia
    Demondion, Pierre
    Marechaux, Sylvestre
    Varnous, Shaida
    Lebreton, Guillaume
    Mouquet, Frederic
    Leprince, Pascal
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 110 (02) : 181 - 187
  • [37] ONSET AND DEVELOPMENT OF CYCLOSPORINE-A EFFECTS ON LYMPHOCYTES OF CARDIAC PATIENTS BEFORE HEART-TRANSPLANTATION
    ALBENGRES, E
    RIANT, P
    MOREL, M
    HAMBERGER, C
    TAVOLARO, O
    LOISANCE, D
    TILLEMENT, JP
    CACHERA, JP
    THERAPEUTIC DRUG MONITORING, 1990, 12 (01) : 2 - 7
  • [38] Cardiac transplantation outcomes in patients with amyloid cardiomyopathy
    Ohiomoba, Ramael O.
    Youmans, Quentin R.
    Ezema, Ashley
    Akanyirige, P.
    Anderson, Allen S.
    Bryant, A.
    Jackson, Kamari
    Mandieka, Edwin
    Pham, Duc T.
    Rich, Jonathan D.
    Yancy, Clyde W.
    Okwuosa, Ike S.
    AMERICAN HEART JOURNAL, 2021, 236 : 13 - 21
  • [39] Dynamic LVEF Decline and Serum NT-proBNP and Uric Acid Levels before Heart Transplantation are Independent Predictors of Adverse Outcomes in Young Adult Patients with Dilated Cardiomyopathy
    Li, Jian
    Mi, Shouling
    Wang, Meng
    Li, Mengwan
    Guo, Qilong
    Yang, Fan
    Ge, Junhua
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (05)
  • [40] Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation
    Barrett, Christopher D.
    Alexander, Kevin M.
    Zhao, Hongyu
    Haddad, Francois
    Cheng, Paul
    Liao, Ronglih
    Wheeler, Matthew T.
    Liedtke, Michaela
    Schrier, Stanley
    Arai, Sally
    Weisshaar, Dana
    Witteles, Ronald M.
    JACC-HEART FAILURE, 2020, 8 (06) : 461 - 468